Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-10-16 10:47 UTC

TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG)

For best results when printing this announcement, please click on link below: TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG) Ionis Pharmaceuticals, Inc. ( ) (Nasdaq: IONS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Euro

IONS.O

News 2026-10-16 10:45 UTC

EU CHMP recommends TRYNGOLZA approval for severe hypertriglyceridemia

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended TRYNGOLZA (olezarsen) for approval in the EU for severe hypertriglyceridemia.

Search market news

Matching instruments

TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG)

EU CHMP recommends TRYNGOLZA approval for severe hypertriglyceridemia